In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Loretta Erhunmwunsee, a thoracic surgeon and lung cancer researcher at City of Hope,.

From her roots in underserved communities to today, where she is at the forefront of lung cancer research, Dr. Erhunmwunsee brings a unique perspective to understanding how environments and where we live can shape our health. Her latest groundbreaking research looks at how air pollution and neighborhood locations may not only increase cancer risk — but also influence tumor biology. She explores why diversity in healthcare matters and shares her vision for making leading-edge cancer care accessible to all.

Follow Us

• LinkedIn @city-of-hope
• X @cityofhope
• Facebook @cityofhope
• Instagram @cityofhope

Presented by City Of Hope
www.CityOfHope.org

What does it take to bring tumor-infiltrating lymphocyte (TIL) therapy to more patients and make the therapy more effective for those already eligible?

In this episode of Edge of Breakthrough, Dr. Monty Pal sits down with Dr. Kelly Mahuron, a surgical oncologist at City of Hope, to unpack how TIL therapy is evolving. From identifying eligible patients and surgical harvesting of TILs to cell expansion and reinfusion, Dr. Mahuron breaks down the entire process of TIL therapy, highlighting how her cross-disciplinary team is working to improve patient outcomes, reduce toxicity, and eventually expand treatment beyond melanoma.

They also explore the next generation of TILs f, and how oncolytic viruses and modified immune environments might bring TILs to more resistant cancers such as pancreatic and colorectal tumors.

Learn how surgical precision, immunotherapy, and translational research come together to push the boundaries of what's possible in cancer treatment. . Tune in to the full conversation now.

Follow Us

• LinkedIn @city-of-hope
• X @cityofhope
• Facebook @cityofhope
• Instagram @cityofhope

Presented by City Of Hope
www.CityOfHope.org

In this episode of On the Edge of Breakthrough, Dr. Monty Pal is joined by Dr. Stephen Forman, a giant of cancer care and hematologic malignancies and pioneer of cellular immunotherapy.

Dr. Forman reflects on decades of progress in bone marrow transplantation, CAR T cell therapy, and the future of cellular therapies. But this conversation isn’t just about lab science. It’s about the human side of innovation: the infrastructure, access, and emotional support needed to truly care for patients through some of the most complex treatments in cancer care.

Dr. Forman also explains the urgency of expanding healthcare access, and reveals the best practices for building scalable models to deliver the next-generation immunotherapy for patients who need them now.

Listen as they unpack what it means to move from an innovative experiment in the lab to real impact on the front lines of cancer care.

Follow Us

• LinkedIn @city-of-hope
• X @cityofhope
• Facebook @cityofhope
• Instagram @cityofhope

Presented by City Of Hope
www.CityOfHope.org